Trials / Completed
CompletedNCT05356936
Pilot Study of Vitamin K2 (MK-7) and Vitamin D3 Supplementation and the Effects on PASC Symptomatology and Inflammatory Biomarkers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 151 (actual)
- Sponsor
- University Hospitals Cleveland Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Participants are being asked to take part in this research study because they have had a previous diagnosis (at least 3 months ago) of COVID-19 and are experiencing persistent, recurrent or even new symptoms, i.e. post-acute sequelae of SARS-CoV-2 (PASC). The Investigators are interested in studying the effects of Vitamin K2 (MK-7) and Vitamin D3 supplementation on PASC symptoms and the underlying inflammatory process.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Vitamin K2 (MK-7) | Participants will receive Vitamin K2 (MK-7) daily by mouth. |
| DIETARY_SUPPLEMENT | Vitamin D3 | Participants will receive Vitamin D3 daily by mouth. |
Timeline
- Start date
- 2022-06-01
- Primary completion
- 2024-04-01
- Completion
- 2024-08-01
- First posted
- 2022-05-02
- Last updated
- 2024-09-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05356936. Inclusion in this directory is not an endorsement.